Frontlight ResearchEarly access
Triple-negative breast cancer trials in Belarus
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleBCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Where
- Brest, Homyel, Minsk
- Age
- 18 years to 74 years
- People
- 124 worldwide
- Run by
- Biocad
See details and how to joinNCT07108309